A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: paclitaxel|DRUG: pertuzumab|DRUG: pertuzumab-placebo|DRUG: trastuzumab [Herceptin]|DRUG: trastuzumab emtansine
Sponsor: Hoffmann-La Roche
Collaborators: Genentech, Inc.